Cerevance secures $51M in funds to advance drugs for Parkinson's and other CNS diseases
Series B financing of $51 million (€47 million) has closed a funding round for a Parkinson’s Disease drug advancing to a phase 2 clinical study.
Archives for February 14, 2023
Upsher-Smith opens contract manufacturing facility
The company announces the completion of its greenfield facility that possesses manufacturing, packaging, and serialization capabilities.
UN report names pharma industry as key contributor to superbugs
The report compiles several of the key factors that are driving the growth of antimicrobial resistance, highlighting the pharmaceutical industry as a key economic sector driving the issue.